FDA Clears Gene Therapy for Inherited Childhood Blindness to Enter Clinical Trials; Opus Plans Human Study
OPGx-RDH12 aims to deliver a functional gene to retinal photoreceptor cells, seeking an opportunity to preserve vision that begins to decline in early childhood. Supporting evidence currently comes only from cells and mice; safety and efficacy in humans will be the next test.